Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5883471 | 1.00 | DPP7 (0.34) | DPP7ABCB1MEN1KMT2A | |
| SCHEMBL18626133 | 0.98 | DPP7 (0.31) | DPP7ABCB1MEN1KMT2A | |
| SCHEMBL14861702 | 0.98 | DPP7 (0.35) | DPP7ABCB1MEN1KMT2A | |
| SCHEMBL339384 | 0.98 | DPP7 (0.35) | DPP7ABCB1MEN1KMT2A | |
| SCHEMBL25315899 | 0.98 | DPP7 (0.35) | DPP7ABCB1MEN1KMT2A | |
| SCHEMBL25312712 | 0.98 | DPP7 (0.35) | DPP7ABCB1MEN1KMT2A | |
| SCHEMBL5883987 | 0.98 | DPP7 (0.31) | DPP7ABCB1MEN1KMT2A | |
| SCHEMBL5883693 | 0.93 | — | — | |
| SCHEMBL25312085 | 0.91 | DPP7 (0.36) | DPP7ABCB1MEN1KMT2A | |
| SCHEMBL10789982 | 0.91 | DPP7 (0.36) | DPP7ABCB1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097752-B2 | Antiprotozoal ring-substituted phospholipids | MAKSCIENTIFIC, LLC (US) | 2012-01-17 | — | — | US | disclosed |
| EP-1578754-A4 | ANTIPROTOZOAL RING-SUBSTITUTED PHOSPHOLIPIDS | MAKSCIENTIFIC LLC (US) | 2006-07-19 | — | — | EP | disclosed |
| US-20060105998-A1 | Antiprotozoal ring-substiuted phospholipids | MAK SCIENTIFIC CORPORATION (US) | 2006-05-18 | — | — | US | disclosed |
| EP-1578754-A2 | ANTIPROTOZOAL RING-SUBSTITUTED PHOSPHOLIPIDS | MakScientific Corporation (US) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004041167-A2 | ANTIPROTOZOAL RING-SUBSTITUTED PHOSPHOLIPIDS | CALOGEROPOULOU THEODORA (GR) | 2004-05-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060105998-A1 | Antiprotozoal ring-substiuted phospholipids | PHOSPHO1, PLTP, PLA2G2C | DPP7 3719/4885ABCB1 730/4885MEN1 2778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.